Bruker Corp. | Income Statement

Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
1,839
1,809
1,624
1,611
1,766
1,896
Cost of Goods Sold (COGS) incl. D&A
1,027
1,021
894
858
947
992
Gross Income
812
788
730
754
819
903
SG&A Expense
628
625
538
540
579
618
EBIT
184
159
-
-
240
280
Unusual Expense
35
61
43
33
25
25
Non Operating Income/Expense
12
16
9
9
3
1
Interest Expense
13
13
13
13
15
13
Pretax Income
125
101
128
178
198
245
Income Tax
43
42
23
23
118
64
Consolidated Net Income
82
60
105
155
80
181
Net Income
80
57
102
154
79
180
Net Income After Extraordinaries
80
57
102
154
79
180
Net Income Available to Common
80
57
102
154
79
180
EPS (Basic)
0.48
0.33
0.60
0.95
0.49
1.14
Basic Shares Outstanding
167
168
168
161
158
156
EPS (Diluted)
0.48
0.33
0.60
0.95
0.49
1.14
Diluted Shares Outstanding
169
170
169
162
159
157
EBITDA
245
219
245
268
304
345
Other Operating Expense
-
4
-
-
-
5
Non-Operating Interest Income
-
1
1
1
1
1
Minority Interest Expense
2
3
3
1
2
1

About Bruker

View Profile
Address
40 Manning Road
Billerica Massachusetts 01821
United States
Employees -
Website http://www.bruker.com
Updated 07/08/2019
Bruker Corp. engages in the development, manufacture and distribution of scientific instruments, and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. It operates through the Bruker Scientific Instruments (BSI) and Bruker Energy and Supercon Technologies (BEST) segments. The BSI segment is comprised of the Bruker BioSpin Group, the Bruker CALID Group, and the Bruker Nano Group.